About the Journal

Aim:

International Medical Biochemistry, Biotechnology, and Genetics journal aims to provide a global platform for the publication of cutting-edge research and advancements in the fields of medical biochemistry, biotechnology, and genetics. The journal focuses on publishing high-quality, peer-reviewed articles that contribute to understanding human health, disease mechanisms, diagnostic tools, and therapeutic interventions. It seeks to promote interdisciplinary collaboration between scientists, healthcare professionals, and biotechnologists by offering insights into the molecular and biochemical underpinnings of diseases, novel biotechnological innovations, and advancements in genetic research.The journal aims to bridge the gap between basic research and clinical applications, ensuring that discoveries are translated into clinically applicable knowledge that can improve patient outcomes and enhance healthcare delivery worldwide. By promoting research from diverse cultural and geographic backgrounds, the journal aspires to highlight global challenges and solutions in the fields of medical biochemistry, biotechnology, and genetics.

 Scope:

The scope of the journal includes, but is not limited to, the following areas:

Medical Biochemistry:

  • Enzyme function and regulation in disease states.
  • Biomarker discovery and validation for diagnosis and prognosis.
  • Metabolic disorders and their molecular mechanisms.
  • Drug metabolism and pharmacokinetics in therapeutic interventions.
  • Role of vitamins, hormones, and nutrients in health and disease.

Medical Biotechnology:

  • Development of biotechnological tools for disease diagnosis and therapy.
  • Advances in gene therapy, cell therapy, and regenerative medicine.
  • Biotechnology-based drug development and delivery systems.
  • Diagnostic and therapeutic innovations in oncology, infectious diseases, and chronic conditions.
  • Applications of CRISPR and other gene-editing technologies in medical research.

Medical Genetics:

  • Genetic predisposition to diseases and hereditary disorders.
  • Role of genomics in personalized medicine and targeted therapies.
  • Genetic counseling, diagnosis, and prevention of inherited diseases.
  • Advances in genomics, proteomics, and epigenetics.
  • Studies on gene-environment interactions and their influence on health.

Translational Research:

  • Translating molecular discoveries into clinical applications.
  • Integrating omics technologies for personalized healthcare solutions.
  • Development of new diagnostic tools, vaccines, and therapies through biotechnological innovations.

Molecular Medicine:

  • Integration of molecular biology and biochemistry to understand disease mechanisms and the development of novel therapeutic strategies.

Bioinformatics and Computational Biology:

  • Application of computational tools and techniques in understanding biochemical and genetic data, predictive modeling in genomics, and protein structure analysis in health and disease.

Pharmacogenomics:

  •  Research on the genetic basis of drug response, personalized medicine, and the development of targeted therapies based on individual genetic profiles.

Systems Biology:

  • Holistic approaches to understanding the interactions and regulatory networks that define the complexity of biological systems in health and disease.

Ethical, Legal, and Social Issues:

  • Ethical considerations in genetic testing and biotechnological innovations.
  • Regulatory and policy aspects related to genetic engineering and biotechnological advancements.
  • Impact of medical genetics and biotechnology on public health and global healthcare systems.